These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 9301450

  • 21. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups.
    J Clin Oncol; 2005 Dec 01; 23(34):8845-52. PubMed ID: 16246977
    [Abstract] [Full Text] [Related]

  • 22. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 23. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF, Greenberg ML, Filler RM.
    J Pediatr Surg; 1997 Jul 20; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [Abstract] [Full Text] [Related]

  • 24. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V].
    Liu G, Liu B, Li K, Dong K, Xiao X.
    Zhonghua Er Ke Za Zhi; 2015 Feb 20; 53(2):119-23. PubMed ID: 25876687
    [Abstract] [Full Text] [Related]

  • 25. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G, International Childhood Liver Tumours Strategy Group (SIOPEL).
    Lancet Oncol; 2013 Aug 20; 14(9):834-42. PubMed ID: 23831416
    [Abstract] [Full Text] [Related]

  • 26. Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
    Sarper N, Corapçioğlu F, Anik Y, Ural D, Yildiz K, Tugay M.
    J Pediatr Hematol Oncol; 2006 Jun 20; 28(6):386-90. PubMed ID: 16794509
    [Abstract] [Full Text] [Related]

  • 27. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.
    Davies JQ, de la Hall PM, Kaschula RO, Sinclair-Smith CC, Hartley P, Rode H, Millar AJ.
    J Pediatr Surg; 2004 Sep 20; 39(9):1321-7. PubMed ID: 15359384
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
    Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L.
    Br J Surg; 2015 Jan 20; 102(1):108-13. PubMed ID: 25349947
    [Abstract] [Full Text] [Related]

  • 32. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
    Sivaprakasam P, Gupta AA, Greenberg ML, Capra M, Nathan PC.
    J Pediatr Hematol Oncol; 2011 Aug 20; 33(6):e226-30. PubMed ID: 21792028
    [Abstract] [Full Text] [Related]

  • 33. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group.
    Lancet Oncol; 2013 Aug 20; 14(9):843-52. PubMed ID: 23823158
    [Abstract] [Full Text] [Related]

  • 34. Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
    Piperno-Neumann S, Ray-Coquard I, Occean BV, Laurence V, Cupissol D, Perrin C, Penel N, Bompas E, Rios M, Le Cesne A, Italiano A, Anract P, de Pinieux G, Collard O, Bertucci F, Duffaud F, Le Deley MC, Delaye J, Brugieres L, Blay JY.
    Int J Cancer; 2020 Jan 15; 146(2):413-423. PubMed ID: 31246277
    [Abstract] [Full Text] [Related]

  • 35. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
    Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara S, Ueda Y, Onitake Y.
    J Pediatr Surg; 2016 Dec 15; 51(12):2053-2057. PubMed ID: 27712887
    [Abstract] [Full Text] [Related]

  • 36. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I, Aoki Y, Ueda T, Araki N, Naka N, Nakanishi H, Matsumine A, Ieguchi M, Mori S, Myoui A, Kuratsu S, Hashimoto N, Yoshikawa H.
    J Chemother; 2013 Feb 15; 25(1):41-8. PubMed ID: 23433444
    [Abstract] [Full Text] [Related]

  • 37. Resectability of advanced liver tumours in children after combination chemotherapy.
    Munro FD, Simpson E, Azmy AF.
    Ann R Coll Surg Engl; 1994 Jul 15; 76(4):253-6. PubMed ID: 8074387
    [Abstract] [Full Text] [Related]

  • 38. Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
    Kusano T, Aoki H, Kinjo T, Miyazato H, Shimoji H, Isa T, Muto Y.
    J Hepatobiliary Pancreat Surg; 2000 Jul 15; 7(4):410-6. PubMed ID: 11180863
    [Abstract] [Full Text] [Related]

  • 39. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
    Fuchs J, Wenderoth M, von Schweinitz D, Haindl J, Leuschner I.
    Cancer; 1998 Dec 01; 83(11):2400-7. PubMed ID: 9840541
    [Abstract] [Full Text] [Related]

  • 40. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ, Palaniappan R, Venkitaraman B, Ranganathan R.
    J Gastrointest Cancer; 2018 Dec 01; 49(4):493-496. PubMed ID: 28963691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.